The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2023

Filed:

Apr. 25, 2021
Applicant:

Nanjing Medical University, Jiangsu, CN;

Inventors:

Yong Ji, Jiangsu, CN;

Liping Xie, Jiangsu, CN;

Shuang Zhao, Jiangsu, CN;

Tianyu Song, Jiangsu, CN;

Yi Han, Jiangsu, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 277/02 (2006.01); A61P 11/06 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 277/02 (2013.01); A61P 11/06 (2018.01); C07D 417/14 (2013.01);
Abstract

Disclosed are a thiazolone derivative of N6022 and a pharmaceutical use thereof. The characteristic structure of the thiazolone derivative of N6022 is: Compared to N6022, the compound of the present disclosure has good oral bioavailability and a longer half-life period. In in-vitro experiments, administering the compound of the present disclosure can improve migration ability, tube formation ability and, the permeability of human umbilical vein endothelial cells caused by high glucose, and administering the compound of the present disclosure at an animal level can obviously promote the angiogenesis and blood flow recovery of ischemic lateral limbs of diabetic mice. Overall, it suggests that the compound of the present disclosure can be used for treating diseases related to diabetic vascular complications.


Find Patent Forward Citations

Loading…